ASTH

Astrana Health Inc

Healthcare · USD

ASTH

Price

$27.395

+5.37%

Cap

$1.5B

Earnings

1/3 beat

30d Trend

+5%

ASTH
Loading chart data...
0 data pointsPowered by Brain47
52-week range56%
18.0834.8

Upper half of range — momentum is positive

Analyst consensus (11 analysts)+28% to target
0 Strong Buy9 Buy2 Hold0 Sell0 Strong Sell

Target range: $26$50 (consensus: $35)

Consensus: Strong Buy

Earnings history

Q4 2025

BEAT

0.54 vs 0.26

Q3 2025

MISS

0.01 vs 0.43

Q2 2025

MISS

0.19 vs 0.35

VolatilityHigh

Key macro factors

·

US Economic Health and Employment: The robust US job market (178,000 jobs added in March, unemployment at 4.3%) could lead to increased enrollment in employer-sponsored health plans, benefiting Astrana Health's service demand, especially as it manages care for various insured patients. [cite: 1, first search result]

·

Global Economic Instability and Inflation: Ongoing Middle East conflict driving oil prices higher and IMF downgrades to global growth forecasts could lead to broader market volatility and increased operational costs for healthcare providers, potentially impacting Astrana Health's margins despite its value-based care model.

·

Government Healthcare Policy & Reimbursement Trends: As Astrana Health serves patients covered by Medicare and Medicaid, changes in government reimbursement policies, regulatory changes, and trends in Medicaid disenrollment or Medicare Advantage rates could directly impact the company's revenue and profitability. [cite: 4, first search result]

Astrana Health, Inc., formerly known as Apollo Medical Holdings, Inc., is a physician-centric, technology-powered, risk-bearing healthcare management company headquartered in Alhambra, California, that provides integrated value-based medical care services across the United States. [cite: 4, 10, 4, first search result]

Next earnings:2026-05-07

QUANT SCORE

Building intelligence for this stock. Brain47 needs a few days of price data to calculate technical indicators and generate a full quant score.

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.

Astrana Health Inc (ASTH) — Brain47 AI Score 44/100 | Analysis